SNSE
Sensei Biotherapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$42.50M
P/E Ratio
—
EPS
$-16.72
Beta
-0.10
52W High
$36.76
52W Low
$5.26
50-Day MA
$23.33
200-Day MA
$12.67
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Sensei Biotherapeutics Inc
Sensei Biotherapeutics, Inc., a clinical-stage immunotherapy company, is dedicated to the discovery and development of therapies with an initial focus on cancer treatments. The company is headquartered in Rockville, Maryland.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-22.15M |
| Operating Margin | 0.00% |
| Return on Equity | -74.00% |
| Return on Assets | -40.80% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $18.24 |
| Price-to-Book | 2.11 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 1.36 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $1.34M |
| Float | 810,860 |
| % Insiders | 30.19% |
| % Institutions | 13.06% |
Data last updated: 4/9/2026